Long-term tolerability and effectiveness of eptinezumab in Japanese adults with chronic migraine: results of the 60-week open-label SUNSET trial.

ABSTRACT:

SUBMITTER: Takeshima T 

PROVIDER: S-EPMC12659320 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature